en 
Ho Chi Minh City, April 22, 2025 – Danh Khoi Group Joint Stock Company (NRC) officially signed a strategic cooperation agreement with Lam Dong Pharmaceutical Joint Stock Company (LADOPHAR) – a reputable enterprise with over 40 years of experience in pharmaceutical production and herbal medicine in Vietnam.
The signing ceremony was solemnly held at NRC’s headquarters with the participation of senior leaders and key representatives from both sides. This event marks a significant milestone in NRC’s sustainable ecosystem strategy — expanding into the pharmaceuticals, medical supplies, and community healthcare sectors.
Scope of Cooperation
Development of Medicinal Material Areas:
Both parties will collaborate to establish herbal cultivation zones aligned with national development planning, ensuring quality standards and full traceability.
Research & Product Development:
Joint efforts will focus on research and development of high-value medical and commercial products.
Business & Market Development:
The two companies will jointly develop and commercialize products from herbal cultivation and pharmaceutical manufacturing — targeting NRC’s ecosystem hospitals, the domestic market, and international markets under agreed business strategies
Leadership Insights
Mr. Nguyen Huy Cuong, CEO of NRC Group, emphasized:
“In realizing our vision of building a sustainable ecosystem, the collaboration with LADOPHAR is a strategic step forward. We believe that LADOPHAR’s proven expertise and reputation, combined with NRC’s expansive ecosystem and business foundation, will generate lasting value, meet rising customer expectations, and contribute to the advancement of Vietnam’s pharmaceutical industry.”
Mr. Le Tien Thinh, CEO of LADOPHAR, shared:
“With NRC’s diverse ecosystem encompassing hospitals, healthcare networks, and regional development projects, coupled with LADOPHAR’s 40-year heritage in pharmaceutical production, this partnership will harmonize our strengths to promote green living projects and integrated healthcare solutions, enhancing community well-being.”
Currently, LADOPHAR stands among Vietnam’s leading pharmaceutical enterprises with GMP-WHO certified factories, international-standard herbal material zones in Da Lat, and a nationwide distribution network.
Meanwhile, NRC operates a multi-sector ecosystem with residential and resort projects, agricultural and medicinal herb development zones, and a network of partner hospitals and medical facilities across key provinces such as Dong Nai, Binh Dinh, Nghe An, and Hanoi.
The collaboration between NRC and LADOPHAR is expected to create sustainable value, leveraging the strengths of both enterprises to foster innovation in pharmaceuticals and healthcare, meeting the growing demand for herbal medicine and medical supplies in both domestic and global markets.
